Cognios Capital’s Bristol-Myers Squibb BMY Stock Holding History

Cognios Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-31,070	Closed	-$1.73M	–	36
2020 Q1	$1.73M	Sell	31,070 -7,559	-20%	-$462K	0.86%	29
2019 Q4	$2.48M	Sell	38,629 -5,581	-13%	-$320K	0.88%	44
2019 Q3	$2.24M	Sell	44,210 -1,338	-3%	-$62.9K	0.83%	59
2019 Q2	$2.06M	Buy	45,548 +4,152	+10%	+$193K	0.79%	80
2019 Q1	$1.97M	Buy	+41,396	New	+$2.06M	0.7%	86
2014 Q3	–	Sell	-5,595	Closed	-$271K	–	81
2014 Q2	$271K	Sell	5,595 -6,133	-52%	-$302K	0.2%	71
2014 Q1	$609K	Hold	11,728	–	–	0.36%	59
2013 Q4	$623K	Buy	+11,728	New	+$597K	0.37%	60

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cognios Capital's BMY Position: Q2 2020 in Review

Cognios Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 31,070 shares — an estimated $1.73M sold.

Cognios Capital first reported a position in BMY in Q4 2013 and held it in 8 quarters. The position peaked at $2.48M in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Cognios Capital reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
Cognios Capital sold 31,070 Bristol-Myers Squibb shares in Q2 2020, an estimated $1.73M.
Cognios Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 8 quarters.
Cognios Capital's Bristol-Myers Squibb position peaked at $2.48M in Q4 2019.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.